Esper Boel
Direktor/Vorstandsmitglied bei MonTa Biosciences ApS
Profil
Esper Boel is currently a Director at MonTa Biosciences ApS.
Prior to this, he held positions as Head-Biotechnology Unit at Novo Nordisk A and Senior Vice President & Head-Discovery at Symphogen A.
Boel received his undergraduate and doctorate degrees from the University of Aarhus in 1979.
Aktive Positionen von Esper Boel
| Unternehmen | Position | Beginn |
|---|---|---|
MonTa Biosciences ApS
 MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Esper Boel
| Unternehmen | Position | Ende |
|---|---|---|
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ausbildung von Esper Boel
| University of Aarhus | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Health Technology |
